Annovis Bio Stock (NYSE: ANVS) stock price, news, charts, stock research, profile.
Open | $11.48 |
Close | $10.75 |
Volume / Avg. | 404.74K / 2.03M |
Day Range | 10.32 - 11.54 |
52 Wk Range | 4.53 - 22.49 |
Market Cap | $119.31M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NYSE |
RSI | 53 |
Short Interest | 15.93% |
Days to Cover | 7.12 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Annovis Bio (NYSE:ANVS) through any online brokerage.
Other companies in Annovis Bio’s space includes: Armata Pharmaceuticals (AMEX:ARMP), Tevogen Bio Holdings (NASDAQ:TVGN), Agenus (NASDAQ:AGEN), aTyr Pharma (NASDAQ:ATYR) and RAPT Therapeutics (NASDAQ:RAPT).
There is no analysis for Annovis Bio.
Annovis Bio has a consensus price target of $39.33.
The stock price for Annovis Bio (NYSE: ANVS) is $10.68 last updated Today at July 22, 2024 at 5:13 PM EDT.
There are no upcoming dividends for Annovis Bio.
Annovis Bio’s Q2 earnings are confirmed for Tuesday, August 13, 2024.
There is no upcoming split for Annovis Bio.
Annovis Bio is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.